L-carnitine prevents the progression of atherosclerotic lesions in hypercholesterolaemic rabbits

Pharmacological Research

Volumn 44, Issue 3, 2001, Pages 235-242

  Sayed Ahmed, Mohamed M ^a   Khattab, Mahmoud M ^b   Gad, Mohamed Z ^c   Mostafa, Nadia ^d  

^a NATIONAL CANCER INSTITUTE   (Egypt)

^b Department of Pharmacology ^*

^c Faculty of Pharmacy

^d CAIRO UNIVERSITY   (Egypt)

Author keywords

Atherosclerosis; Carnitine deficiency; D carnitine; Hypercholesterolaemic rabbits; L carnitine; Reduced glutathione and malondialdhyde

Indexed keywords

CARNITINE; GLUTATHIONE; MALONALDEHYDE;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROSCLEROSIS; CARNITINE DEFICIENCY; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DRUG EFFECT; HISTOPATHOLOGY; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RISK FACTOR;

EID: 0034834828     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.2001.0852     Document Type: Article

References (28)

1. The pathogenesis of atherosclerosis: A prospective of the 1990s
2. Endothelial alterations in hypercholesterolemia: More than simply vasodilator dysfunction
3. Mechanism of disease: Atherosclerosis - An inflammatory disease
4. L-carnitine treatment in the hyperlipidemic rabbit
5. Propionyl-l-carnitine prevents the progression of atherosclerotic lesions in aged hyperlipemic rabbits
6. The effect of l-carnitine on fat diet-induced hyperlioidemia in the rat
7. L-carnitine effect on plasma lipoproteins of hyperlipidemic fat-loaded rats
8. Effect of l-carnitine treatment on very low density lipoprotein kinetics in the hyperlipidemic rabbit
9. The effect of l-carnitine on cholesterol metabolism in rat (Rattus bubalus) hepatocyte cells
10. Protection of the ischemic myocardium by l-propionylcarnitine: Effects on the recovery of cardiac output after ischemia and reperfusion, carnitine transport, and fatty acid oxidation
11. Carnitine and its derivatives in cardiovascular disease
12. Carnitine deficiency-induced cardiomyopathy
13. Effect of thymosin fraction 5(F5) on erythrocyte glutathion and lipid peroxide levels in hypercholesterolemic rabbits
14. Tissue specific depletion of l-carnitine in rat heart and skeletal muscle by D-carnitine
15. L-carnitine treatment improves cardiac performance and restores high energy phosphate pools in cardlomyopathic Syrian hamster
16. Enhancement of activities relative to fatty acid oxidation in the liver of rats depleted of l-carnitine by D-carnitine and gamma-butyrobetaine hydroxylase inhibitors
17. Study of the hypolipidemic properties of pectin, garlic and ginseng in hypercholesterolemic rabbits
18. Tissue sulfhydryl groups
19. Microsomal lipid peroxidation
20. Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle
21. Carnitine in metabolism of paced cardiac and skeletal muscles: Prevention of acidosis and improvement of vascular flow
22. Myocardial carnitine deficiency in human cardiomyopathy
23. Carnitine metabolism during exercise in patients with peripheral vascular disease
24. Carnitine metabolism in peripheral arterial disease
25. Role of oxidized LDL and antioxidants in atherosclerosis
26. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells
27. Is the carnitine system part of the heart antioxidant network?